The Adverse Effect of Overweight in Assisted Reproduction Treatment Outcomes
Overview
Authors
Affiliations
Objective: To assess Body Mass Index (BMI) effects on the results obtained from ICSI cycles.
Methods: We studied 266 ICSI cycles performed between January 2014 and December 2016. The patients were grouped according to their BMI in: Normal (18.5-24.9), Overweight (25.0-29.9) and Obese (>30). We compared the following variables between the groups: number of antral follicles, ovarian stimulation length, gonadotropin dose used, maximum estradiol level, follicles developed/antral follicles, retrieved oocytes/developed follicles and mature/retrieved oocytes, normal fertilization rate, embryo achieved/normal fertilized oocytes, clinical pregnancy and implantation rates. We used the Kruskal-Wallis and the Chi square tests. p<0.05 was considered significant.
Results: Normal, Overweight and Obese patients presented comparable values for number of antral follicles (11.6±5.4, 12.5±5.5, 12.2±5.7), ovarian stimulation length (7.5±1.4, 7.6±1.1, 7.8±1.3) and gonadotropin dose used (2043±489, 1940±536, 2109±605). Obese patients had lower values of estradiol (1560±610, 1511±635, 1190±466; p=0.018), developed follicles (81%, 76%, 70%; p<0.0001), and retrieved oocytes (91%, 90%, 84%; p=0.0017); and not significantly lower values of mature oocytes (82%, 82%, 77%; p=0.26). The groups had comparable fertilization rates (72%, 73%, 69%) and embryo achieved rates (67%, 63%, 72%). The normal group had higher, but not significantly higher pregnancy and implantation rates (43%, 40%, 38%, p=0.53; and 33%, 26%, 23%; p=0.11), and significantly higher ongoing pregnancy rates (37%, 33%, 33%, p=0.042).
Conclusion: Increased BMI patients had impaired ovarian response and lower pregnancy rates in ICSI cycles.
Wang Q, Lang J, Zhi Y, Zhu X, Fu Y J Assist Reprod Genet. 2025; .
PMID: 39806215 DOI: 10.1007/s10815-024-03386-1.
Turner F, Powell S, Al-Lamee H, Gadhvi A, Palmer E, Drakeley A BMJ Open. 2024; 14(10):e082123.
PMID: 39486817 PMC: 11529583. DOI: 10.1136/bmjopen-2023-082123.
Economic perspective of evaluating fertility treatment in obese and overweight infertile women.
Rafique M, Al-Badr A, Saleh A, Al-Jaroudi D Saudi Med J. 2021; 42(6):666-672.
PMID: 34078730 PMC: 9149712. DOI: 10.15537/smj.2021.42.6.20200733.
Garcia-Ferreyra J, Carpio J, Zambrano M, Valdivieso-Mejia P, Valdivieso-Rivera P JBRA Assist Reprod. 2021; 25(3):394-402.
PMID: 33710838 PMC: 8312282. DOI: 10.5935/1518-0557.20200105.
Roles of kisspeptin in IVF/ICSI-treated infertile women and in human granulosa cells.
Qin L, Sitticharoon C, Petyim S, Keadkraichaiwat I, Sririwichitchai R, Maikeaw P Exp Biol Med (Maywood). 2020; 246(8):996-1010.
PMID: 33327782 PMC: 8024506. DOI: 10.1177/1535370220981006.